All In MedTech

Device Trial Radar · NCT02813421

Continue Glucose Monitoring Before Insulin Pump

Professional Continuous Glucose Monitoring Before Starting Insulin Pump Therapy

Last checked: Nov 20, 2026Latest source record: May 25, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

11

Actual

Start

Mar 2016

Primary completion

May 1, 2017

Study completion May 1, 2017

Sponsor

Lead sponsor
Children's Hospital Los AngelesAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 27, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
Who can join
All sexes, from 2 years, up to 24 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to learn more about blood glucose control when people with Type 1 Diabetes switch to an insulin pump. The investigators hope to learn whether using a continuous glucose monitor (CGM) helps to create personalized insulin doses that may lead to stable blood glucoses and less frequent insulin pump dose changes during the transition to an insulin pump.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

  • CGM InformedDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage Time Within Target Blood Glucose (Range: 70-180 mg/dL)Time frame: First 6 weeks of insulin pump therapy

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Children's Hospital Los Angeles

    Los Angeles, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.